Field note 002 · Evidence
Traditional use is a category—not a clinical conclusion
Tradition can document what people have done and why. It cannot, by itself, answer every modern question about efficacy, dose, interactions, or safety.
01 / Preserve the category
Traditional use is information with a specific scope.
Traditional-use records can preserve preparation, cultural context, duration of use, and the purposes associated with a plant. Treating that record as worthless loses information. Treating it as proof from a controlled clinical trial changes what the information can support.
The European Medicines Agency explicitly distinguishes traditional-use registration from well-established use. The pathways ask different questions and require different evidence. That distinction is a useful reading habit even when a page is educational rather than regulatory.
02 / Read the preparation
Evidence belongs to the material that was studied.
A trial may study a named extract at a defined concentration and dose. A monograph may cover only certain preparations. Laboratory findings may concern isolated constituents. None of those automatically describes a loose botanical sold under the same common name.
Before carrying a finding into a product description, ask whether the species, plant part, extraction method, route, dose, and population match. If they do not, describe the boundary rather than borrowing certainty.
03 / A practical evidence ladder
Labels should orient, not score.
Lot & Leaf uses evidence labels to show what kind of record exists. They are not badges of effectiveness and they do not replace reading the underlying source.
- Traditional: documented history of use, not a clinical conclusion
- Monograph: an authoritative assessment exists for defined material or preparations
- Limited human research: relevant studies exist but may be small, mixed, or preparation-specific
- Preclinical: laboratory or animal findings without adequate human confirmation
- No established dose: no reliable standardized medical dose for the described preparation
04 / Safety is not a footnote
Natural origin does not remove interaction risk.
The FDA and NCCIH both caution that botanical or dietary-supplement ingredients can have strong effects and can interact with medicines. Pregnancy, nursing, surgery, respiratory conditions, cardiovascular conditions, and individual medicines can change the risk calculation.
An honest educational page states what it does not establish and points readers toward qualified, individualized guidance. That is not timid writing. It is accurate writing.
Primary source trail
Read beyond the summary.
- EMA — Herbal medicinal products ↗Regulatory overview distinguishing traditional and well-established use.
- FDA — FDA 101: Dietary Supplements ↗Consumer guidance on evidence, adverse effects, and interactions.
- NCCIH — Know the Science ↗Tools for reading complementary-health claims and research.